Stay updated on Pembrolizumab and Mifepristone in Advanced Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Mifepristone in Advanced Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Mifepristone in Advanced Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision: v3.4.3 added and Revision: v3.4.2 removed. This change is an administrative update to the page version history and does not affect study details.
    Difference
    0.1%
    Check dated 2026-03-06T18:26:12.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2 replacing Revision: v3.4.1. This is a minor site update and does not change study details or how the page functions.
    Difference
    0.1%
    Check dated 2026-02-13T12:46:45.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    - Revision: v3.4.1 was added and v3.4.0 was removed, reflecting a minor page version update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T09:20:11.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Introduced show/hide glossary controls and updated metadata labels (e.g., Last Update Submitted that Met QC Criteria, Last Update Posted) with a new Revision: v3.4.0; older labels such as Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4 were removed or renamed.
    Difference
    0.4%
    Check dated 2026-01-22T17:41:31.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision v3.3.4 was added and Revision v3.3.3 was removed as footer metadata. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T10:32:34.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The study status is now Terminated, side effect 'rash' has been added to the adverse events, and completion/enrollment dates have been updated.
    Difference
    0.7%
    Check dated 2025-12-24T23:25:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Mifepristone in Advanced Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Mifepristone in Advanced Breast Cancer Clinical Trial page.